Page 1 | Search Results | Hematology, ASH Education Program

1-7 of 7

Sort by

Sort Order Select

Journal Articles

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

Brady L. Stein, Karlyn Martin

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 397–406.

https://doi.org/10.1182/hematology.2019001318

Published: 2019

Journal Articles

New insights into the pathophysiology and development of novel therapies for sickle cell disease

Scott Moerdler, Deepa Manwani

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 493–506.

https://doi.org/10.1182/asheducation-2018.1.493

Published: 2018

Journal Articles

Evolving treatment paradigms in sickle cell disease

Ramasamy Jagadeeswaran, Angela Rivers

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 440–446.

https://doi.org/10.1182/asheducation-2017.1.440

Published: 2017

Journal Articles

Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease?

Joshua J. Field

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 426–432.

https://doi.org/10.1182/asheducation-2015.1.426

Published: 2015

Journal Articles

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

Deepa Manwani, Paul S. Frenette

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 362–369.

https://doi.org/10.1182/asheducation-2013.1.362

Published: 2013

Journal Articles

The Role of Platelets in Atherothrombosis

Zane S. Kaplan, Shaun P. Jackson

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 51–61.

https://doi.org/10.1182/asheducation-2011.1.51

Published: 2011

Journal Articles

Coagulation in the Pathophysiology of Hemolytic Anemias

Maria Domenica Cappellini

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 74–78.

https://doi.org/10.1182/asheducation-2007.1.74

Published: 2007

NARROW

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

New insights into the pathophysiology and development of novel therapies for sickle cell disease

Evolving treatment paradigms in sickle cell disease

Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease?

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

The Role of Platelets in Atherothrombosis

Coagulation in the Pathophysiology of Hemolytic Anemias

ASH Publications

American Society of Hematology

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms

New insights into the pathophysiology and development of novel therapies for sickle cell disease

Evolving treatment paradigms in sickle cell disease

Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease?

Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies

The Role of Platelets in Atherothrombosis

Coagulation in the Pathophysiology of Hemolytic Anemias

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only